Reducing HIV-related stigma through building resilience
Mitigate the effect of HIV-related stigma through a resilience approach
This study is looking to help people living with HIV/AIDS in Guangxi, China, by creating a supportive program that boosts their strengths and helps reduce the stigma they face, so they can get better access to care and treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11006233 on NIH RePORTER |
What this research studies
This research aims to address the stigma and discrimination faced by individuals living with HIV/AIDS, which significantly hinders their access to treatment and care. By focusing on a resilience approach, the study will develop and implement an intervention that enhances the strengths and resources of people living with HIV and their families, as well as healthcare providers. The intervention will be tested through a randomized trial involving 800 participants in Guangxi, China, to evaluate its effectiveness in mitigating stigma and improving care outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV/AIDS and their family members, as well as healthcare providers involved in their care.
Not a fit: Patients who are not living with HIV/AIDS or do not have a direct connection to someone who is may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved mental health and treatment adherence for individuals living with HIV by reducing stigma.
How similar studies have performed: While resilience approaches have shown promise in preliminary research, this specific intervention has not been widely tested in prior studies.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Li, Xiaoming — University of South Carolina at Columbia
- Study coordinator: Li, Xiaoming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.